Immunotherapy targeting the obese white adipose tissue microenvironment: Focus on non-communicable diseases.

"Declaration of competing interest D.Y.L. is CEO & Funder of Elixir Pharmatech Inc., no of whom contributed or was involved in this research. All other authors declare no conflict of interest."

"This research was supported by the 10.13039/501100003725National Research Foundation of Korea (NRF) grant funded by the Korea government Ministry of Science and ICT (MSIT) (No. NRF-2022R1A4A1030421 and NRF-2020R1A2C3005834). Lia Priscilla: Conceptualization, Formal analysis, Visualization, Writing – original draft, Writing – review & editing. Chaerim Yoo: Conceptualization, Formal analysis, Visualization, Writing – original draft, Writing – review & editing. Seonmi Jang: Formal analysis, Visualization, Writing – original draft. Sewon Park: Formal analysis, Visualization, Writing – original draft. Gayoung Lim: Formal analysis, Visualization, Writing – original draft. Taekyun Kim: Formal analysis, Visualization, Writing – original draft. Dong Yun Lee: Conceptualization, Formal analysis, Funding acquisition, Project administration, Supervision, Validation, Visualization, Writing - original draft, Writing – review & editing."